As of 2025-04-23, the Intrinsic Value of Pliant Therapeutics Inc (PLRX) is -17.17 USD. This PLRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.50 USD, the upside of Pliant Therapeutics Inc is -1,244.70%.
Based on its market price of 1.50 USD and our intrinsic valuation, Pliant Therapeutics Inc (PLRX) is overvalued by 1,244.70%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -17.17 - -17.17 | -17.17 | -1,244.70% |
| P/E | (57.21) - (68.20) | (60.96) | -4163.7% |
| DDM - Stable | (45.67) - (238.91) | (142.29) | -9585.9% |
| DDM - Multi | (6.48) - (26.36) | (10.41) | -793.7% |
| Market Cap (mil) | 91.86 |
| Beta | 1.20 |
| Outstanding shares (mil) | 61.24 |
| Enterprise Value (mil) | 50.88 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.28% |
| Cost of Debt | 5.00% |
| WACC | 6.37% |